These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 36972759)

  • 1. Update in the Treatment of the Complications of Cirrhosis.
    Abraldes JG; Caraceni P; Ghabril M; Garcia-Tsao G
    Clin Gastroenterol Hepatol; 2023 Jul; 21(8):2100-2109. PubMed ID: 36972759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transjugular intrahepatic portosystemic shunt (TIPS) placement at index portal hypertensive decompensation (anticipant TIPS) in cirrhosis and the role of early intervention in variceal bleeding and ascites.
    Rajesh S; Philips CA; Betgeri SS; George T; Ahamed R; Mohanan M; Augustine P
    Indian J Gastroenterol; 2021 Aug; 40(4):361-372. PubMed ID: 34324168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension.
    Colombato L
    J Clin Gastroenterol; 2007; 41 Suppl 3():S344-51. PubMed ID: 17975487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early TIPS with covered stents versus standard treatment for acute variceal bleeding in patients with advanced cirrhosis: a randomised controlled trial.
    Lv Y; Yang Z; Liu L; Li K; He C; Wang Z; Bai W; Guo W; Yu T; Yuan X; Zhang H; Xie H; Yao L; Wang J; Li T; Wang Q; Chen H; Wang E; Xia D; Luo B; Li X; Yuan J; Han N; Zhu Y; Niu J; Cai H; Xia J; Yin Z; Wu K; Fan D; Han G;
    Lancet Gastroenterol Hepatol; 2019 Aug; 4(8):587-598. PubMed ID: 31153882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transjugular intrahepatic portosystemic shunts and portal hypertension-related complications.
    Siramolpiwat S
    World J Gastroenterol; 2014 Dec; 20(45):16996-7010. PubMed ID: 25493012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver-HERO: hepatorenal syndrome-acute kidney injury (HRS-AKI) treatment with transjugular intrahepatic portosystemic shunt in patients with cirrhosis-a randomized controlled trial.
    Ripoll C; Platzer S; Franken P; Aschenbach R; Wienke A; Schuhmacher U; Teichgräber U; Stallmach A; Steighardt J; Zipprich A;
    Trials; 2023 Apr; 24(1):258. PubMed ID: 37020315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Episodic overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt does not increase mortality in patients with cirrhosis.
    Nardelli S; Riggio O; Marra F; Gioia S; Saltini D; Bellafante D; Adotti V; Guasconi T; Ridola L; Rosi M; Caporali C; Fanelli F; Roccarina D; Bianchini M; Indulti F; Spagnoli A; Merli M; Vizzutti F; Schepis F
    J Hepatol; 2024 Apr; 80(4):596-602. PubMed ID: 38097113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transjugular intrahepatic portosystemic shunt in decompensated cirrhotic patients in a tertiary hospital in southern Brazil.
    Titton CM; Torikachvili M; Rêgo HMC; Medronha EF; Ziemiecki Junior E; Ribas C; Ceratti CG; Mattos AA; Tovo CV
    Rev Assoc Med Bras (1992); 2023; 69(4):e20220944. PubMed ID: 37075438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Portosystemic shunts versus endoscopic intervention with or without medical treatment for prevention of rebleeding in people with cirrhosis.
    Simonetti RG; Perricone G; Robbins HL; Battula NR; Weickert MO; Sutton R; Khan S
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD000553. PubMed ID: 33089892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoscopic diagnosis and management of esophagogastric variceal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) Guideline.
    Gralnek IM; Camus Duboc M; Garcia-Pagan JC; Fuccio L; Karstensen JG; Hucl T; Jovanovic I; Awadie H; Hernandez-Gea V; Tantau M; Ebigbo A; Ibrahim M; Vlachogiannakos J; Burgmans MC; Rosasco R; Triantafyllou K
    Endoscopy; 2022 Nov; 54(11):1094-1120. PubMed ID: 36174643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TIPS for management of portal-hypertension-related complications in patients with cirrhosis.
    Allaire M; Walter A; Sutter O; Nahon P; Ganne-Carrié N; Amathieu R; Nault JC
    Clin Res Hepatol Gastroenterol; 2020 Jun; 44(3):249-263. PubMed ID: 31662286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying optimal candidates for early TIPS among patients with cirrhosis and acute variceal bleeding: a multicentre observational study.
    Lv Y; Zuo L; Zhu X; Zhao J; Xue H; Jiang Z; Zhuge Y; Zhang C; Sun J; Ding P; Ren W; Li Y; Zhang K; Zhang W; He C; Zhong J; Peng Q; Ma F; Luo J; Zhang M; Wang G; Sun M; Dong J; Bai W; Guo W; Wang Q; Yuan X; Wang Z; Yu T; Luo B; Li X; Yuan J; Han N; Zhu Y; Niu J; Li K; Yin Z; Nie Y; Fan D; Han G
    Gut; 2019 Jul; 68(7):1297-1310. PubMed ID: 30415233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term clinical outcome and survival predictors in patients with cirrhosis after 10-mm-covered transjugular intrahepatic portosystemic shunt.
    Tejedor-Tejada J; Fuentes-Valenzuela E; García-Pajares F; Nájera-Muñoz R; Almohalla-Álvarez C; Sánchez-Martín F; Calero-Aguilar H; Villacastín-Ruiz E; Pintado-Garrido R; Sánchez-Antolín G
    Gastroenterol Hepatol; 2021 Nov; 44(9):620-627. PubMed ID: 33249114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of Liver Decompensation in Advanced Chronic Liver Disease: Ascites, Hyponatremia, and Gastroesophageal Variceal Bleeding.
    Baiges A; Hernández-Gea V
    Clin Drug Investig; 2022 Jun; 42(Suppl 1):25-31. PubMed ID: 35476218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term effects and complications of the transjugular intrahepatic portosystemic shunt: a single-centre experience.
    Kraglund F; Jepsen P; Amanavicius N; Aagaard NK
    Scand J Gastroenterol; 2019 Jul; 54(7):899-904. PubMed ID: 31203699
    [No Abstract]   [Full Text] [Related]  

  • 16. Reduction of portosystemic gradient during transjugular intrahepatic portosystemic shunt achieves good outcome and reduces complications.
    Luo SH; Zhou MM; Cai MJ; Han SL; Zhang XQ; Chu JG
    World J Gastroenterol; 2023 Apr; 29(15):2336-2348. PubMed ID: 37124886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transjugular intrahepatic portosystemic shunt in cirrhosis: An exhaustive critical update.
    Rajesh S; George T; Philips CA; Ahamed R; Kumbar S; Mohan N; Mohanan M; Augustine P
    World J Gastroenterol; 2020 Oct; 26(37):5561-5596. PubMed ID: 33088154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical portosystemic shunts versus transjugular intrahepatic portosystemic shunt for variceal haemorrhage in people with cirrhosis.
    Brand M; Prodehl L; Ede CJ
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD001023. PubMed ID: 30378107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors analysis of endoscopy and TIPS in the treatment of secondary esophagogastric varicose bleeding with cirrhosis.
    Liu X; Wang Y; Zheng L; Zhu J
    Afr Health Sci; 2023 Sep; 23(3):655-663. PubMed ID: 38357146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The presence of spontaneous portosystemic shunts increases the risk of complications after transjugular intrahepatic portosystemic shunt (TIPS) placement.
    Borentain P; Soussan J; Resseguier N; Botta-Fridlund D; Dufour JC; Gérolami R; Vidal V
    Diagn Interv Imaging; 2016 Jun; 97(6):643-50. PubMed ID: 26947721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.